therapy
In the CIBIS trial, they are those patients with the lower left       ventricular ejection fractions and those who have nonlethal cardiovascular events       but in whom beta-blocker therapy is not permanently discontinued.
In the CIBIS trial, they are those patients with the lower left       ventricular ejection fractions and those who have nonlethal cardiovascular events       but in whom  @OBJECT$  @PREDICAT$  @SUBJECT$  is not permanently discontinued.